Edward Robert Scheffer Cliff

41PUBLICATIONS
120CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Jul 24, 2025
Patient Preferences on Clinical Decision Making in Multiple Myeloma.

Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger

|Jun 14, 2025
Medicare spending and use of subcutaneous biologic formulations with hyaluronidase.

John Kim, Aaron S Kesselheim, Edward R Scheffer Cliff

|Jan 08, 2025
Financial challenges of being on long-term, high-cost medications.

Cleopatra Elshiekh, Roberta Rudà, Edward R Scheffer Cliff

Pageof 7

Frequent Collaborators

12 joint publications

Ghulam Rehman Mohyuddin

7 joint publications

Rajshekhar Chakraborty

5 joint publications

Aaron S Kesselheim

5 joint publications

David A Russler-Germain